Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2008 08:00 ET | Source: Cytomedix, Inc.

Cytomedix to Present At Rodman & Renshaw 10th Annual Healthcare Conference On Wednesday, Nov. 12, 2008

ROCKVILLE, Md., Oct. 20, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that Chief Executive Officer Martin Rosendale will present an overview of the Company at the Rodman &...
September 19, 2008 13:00 ET | Source: Cytomedix, Inc.

Cytomedix On Track With Sales and Marketing Efforts for AutoloGel System and Further Development of CT-112 Peptide, Annual Meeting Told

ROCKVILLE, Md., Sept. 19, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) Chief Executive Officer Martin Rosendale told the Annual Meeting of Shareholders today that the Company is progressing...
September 10, 2008 07:30 ET | Source: Cytomedix, Inc.

Cytomedix Appoints Dr. Peter A. Clausen as Vice President of Business Development

ROCKVILLE, Md., Sept. 10, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced the appointment of Dr. Peter Anton Clausen, Ph.D., a seasoned biochemist with nearly 15 years experience...
September 08, 2008 07:30 ET | Source: Cytomedix, Inc.

Cytomedix Completes $1.5 Million Capital Raise

ROCKVILLE, Md., Sept. 8, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has successfully completed a $1.5 million capital raise through the issuance of two million shares...
August 19, 2008 07:30 ET | Source: Cytomedix, Inc.

Cytomedix CEO Martin Rosendale Discusses Company in Interview With The Wall Street Transcript

ROCKVILLE, Md., Aug. 19, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that The Wall Street Transcript (TWST) has published an in-depth interview with Chief Executive Officer...
July 28, 2008 07:30 ET | Source: Cytomedix, Inc.

Cytomedix Retains Dr. David F. Counts, Inventor of Company's Anti-Inflammatory Peptide Patent

ROCKVILLE, Md., July 28, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that David F. Counts Ph.D., a leading pharmacologist and medical researcher who discovered the Company's...
July 16, 2008 07:30 ET | Source: Cytomedix, Inc.

Cytomedix CEO Issues Shareholder Update

ROCKVILLE, Md., July 16, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) announced today that Chief Executive Officer Martin Rosendale issued the following letter to shareholders providing a...
June 12, 2008 07:30 ET | Source: Cytomedix, Inc.

Cytomedix Unveils Clinical Plans for the Development of Anti-Inflammatory Peptides

ROCKVILLE, Md., June 12, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced plans for entering the multi-billion dollar anti-inflammatory market with patent protected peptides derived...
June 09, 2008 07:30 ET | Source: Cytomedix, Inc.

Cytomedix Announces Transition of Leadership

ROCKVILLE, Md., June 9, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that Kshitij Mohan, Ph.D. will step down as Chairman and CEO effective June 30, 2008, but will continue as a...
May 14, 2008 07:30 ET | Source: Cytomedix, Inc.

Cytomedix Joins the Acute Long Term Hospital Association (ALTHA) as An Allied Member

ROCKVILLE, Md., May 14, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has joined the Acute Long Term Hospital Association (ALTHA) as a Silver member and will be...